SS 37 - Radiation-Immune Crosstalk in Tumor and Normal Tissue Response

Presentations

• 02:15pm - 02:25pm ET

  Type I IFN Drives ILC2 to ILC1 Plasticity in Radiation-Induced Lung Injury

  Speaker: Jaeho Kim, MD - City of Hope, Glendale
• 02:25pm - 02:35pm ET

  Radiotherapy Reshapes the Tumor Immune Microenvironment through PD-L1⁺ Macrophages and Enhances Immunotherapy Efficacy in pMMR Colorectal Cancer

  Speaker: Luoxi He, - Fudan University Shanghai Cancer Center, Shanghai
• 02:35pm - 02:45pm ET

  A Novel Therapeutic Approach Using citVIM-specific CAR-T cells and Radiotherapy to Target NSCLC and Pancreatic Cancer Cells

  Speaker: Yorleny Vicioso Mora, MD, PhD, BS - Duke University, Durham
• 02:45pm - 02:55pm ET

  Targeting TREM2+ Macrophages Overcomes Radiotherapy Resistance

  Speaker: Shuhua Wei, PhD - Peking University Third Hospital, Department of Radiation Oncology, Beijing
• 02:55pm - 03:05pm ET

  Fluorescence Tracking Identifies Tumor-Draining Lymph Node as a Source of CD8 T Cells and Early Type I IFN-Mediated Activation after Tumor Radiation

  Speaker: David Friedman, PhD - Earle A. Chiles Research Institute, Portland
• 03:05pm - 03:15pm ET

  Blockade of PD-1/PD-L1 Pathway Regulates Microglia Activation and Glycolipid Metabolism Via GPD1 to Ameliorate Radiation-Induced Brain Injury

  Speaker: Rong Zheng, MD, PhD - Fujian Medical University Union Hospital, Fuzhou
• 03:15pm - 03:25pm ET

  Discussant

  Speaker: Gaorav Gupta, MD, PhD - University of North Carolina, Chapel Hill